| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/30/2001 | US20010018180 Medical diagnosis |
| 08/30/2001 | US20010017269 Consists of an electrode, a hydrogen peroxide sensor layer on the electrode comprising thermostable peroxidase and non-leachable redox ceners for transferring electrones between electrode and peroxidase, and glucose oxidase enzyme |
| 08/30/2001 | EP1144693A3 Detection of anti-hepatitis b drug resistance |
| 08/30/2001 | CA2437298A1 Method for correlating blood coagulation activity with markers in body fluids, e.g. urine |
| 08/30/2001 | CA2401868A1 Molecules for diagnostics and therapeutics |
| 08/30/2001 | CA2401647A1 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | CA2401256A1 A process for constructing dna based molecular marker for enabling selection of drought and diseases resistant germplasm screening |
| 08/30/2001 | CA2401233A1 Method for detecting cytosine methylation in dna samples |
| 08/30/2001 | CA2401198A1 Ligase/polymerase method for detecting cytosine methylation in dna samples |
| 08/30/2001 | CA2401195A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401063A1 Solution and crystal structures of mmp-13 active site and uses thereof |
| 08/30/2001 | CA2401019A1 Genomic analysis of trna gene sets |
| 08/30/2001 | CA2401018A1 Platform for the discovery of the bacterial genes involved in rna modification |
| 08/30/2001 | CA2400915A1 Estrogen receptor alpha variants and methods of detection thereof |
| 08/30/2001 | CA2400890A1 Method and system for the assembly of a whole genome using a shot-gun data set |
| 08/30/2001 | CA2400863A1 Staphylococcal gtpase obg nucleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | CA2400842A1 Novel compounds |
| 08/30/2001 | CA2400831A1 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | CA2400789A1 Microarray fabrication techniques and apparatus |
| 08/30/2001 | CA2400710A1 Starch branching enzyme |
| 08/30/2001 | CA2400651A1 Electrochemical sensor for determining blood clotting, corresponding system for measuring blood clotting and method for determining blood clotting |
| 08/30/2001 | CA2400606A1 New phosphodiesterase type 7b |
| 08/30/2001 | CA2400443A1 103p2d6: tissue specific protein highly expressed in various cancers |
| 08/30/2001 | CA2400441A1 Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/30/2001 | CA2400088A1 Differential expression screening method |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/30/2001 | CA2399999A1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | CA2399404A1 Screening methods for gram-positive enterococcal virulence factors |
| 08/30/2001 | CA2399259A1 Endometriosis-related markers and uses thereof |
| 08/30/2001 | CA2399258A1 Analysis of biological targets using a biochip comprising a fluorescent marker |
| 08/30/2001 | CA2399241A1 Improved methods for generating catalytic proteins |
| 08/30/2001 | CA2398275A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | CA2397742A1 Method for transdermal sampling of analytes |
| 08/30/2001 | CA2397705A1 Compounds related to or derived from gfr.alpha.4 and their use |
| 08/30/2001 | CA2370803A1 Methods for identifying a protease inhibitor |
| 08/29/2001 | EP1128311A2 A method and system for DNA analysis |
| 08/29/2001 | EP1128310A2 Chemical array fabrication |
| 08/29/2001 | EP1127944A1 Method for screening compound inhibiting signal transduction of inflammatory cytokine |
| 08/29/2001 | EP1127943A2 Means and methods for the expression of homologous and heterologous proteins in strains of Rhodococcus |
| 08/29/2001 | EP1127941A1 Novel dna fragment elevating gene expression dose |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127579A2 Method for increasing bioavailability of oral pharmaceutical compositions |
| 08/29/2001 | EP1127486A1 A method for production of a transgenic animal |
| 08/29/2001 | EP1127277A1 Polyglutamine-containing proteins in neuropsychiatric disorders |
| 08/29/2001 | EP1127259A2 Thromboplastin reagents and methods for preparing and using such reagents |
| 08/29/2001 | EP1127170A1 Human pan-hcv human monoclonal antibodies |
| 08/29/2001 | EP1127169A1 Detection of negative-strand rna viruses |
| 08/29/2001 | EP1127168A2 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 08/29/2001 | EP1127167A1 Methods for preventing cross-contamination in solid support-based assays |
| 08/29/2001 | EP1127166A1 Amplified array analysis method and system |
| 08/29/2001 | EP1127165A1 Method and test kit for analyzing dns repair |
| 08/29/2001 | EP1127164A1 PHARMACOLOGICAL TARGETING OF mRNA CAP FORMATION |
| 08/29/2001 | EP1127163A2 A method for genomic substractive hybridization |
| 08/29/2001 | EP1127162A1 METHODS AND KITS FOR DETECTION OF $i(CRYPTOSPORIDIUM PARVUM) |
| 08/29/2001 | EP1127161A1 Method for making complementary oligonucleotide tag sets |
| 08/29/2001 | EP1127160A2 Parallel methods for genomic analysis |
| 08/29/2001 | EP1127159A1 METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSENGER RNAs |
| 08/29/2001 | EP1127158A1 Use of dna identification techniques for the determination of genetic material of cocoa in fermented or roasted beans and chocolate |
| 08/29/2001 | EP1127157A1 METHYLATED CpG ISLAND AMPLIFICATION (MCA) |
| 08/29/2001 | EP1127156A1 Regulation of nitric oxide synthase activity |
| 08/29/2001 | EP1127139A2 Compositions and methods for identifying mammalian malonyl coa decarboxylase inhibitors, agonists and antagonists |
| 08/29/2001 | EP1127138A1 Alpha 1,2 fucosyltransferase from helicobacter pylori |
| 08/29/2001 | EP1127135A2 High fidelity thermostable ligase and uses thereof |
| 08/29/2001 | EP1127133A2 Polypeptide mediating cell permeability |
| 08/29/2001 | EP1127131A2 Connective tissue growth factor (ctgf) and methods of use |
| 08/29/2001 | EP1127129A1 Myosin heavy chain homolog |
| 08/29/2001 | EP1127128A1 Isolated vshk-1 receptor polypeptides and methods of use thereof |
| 08/29/2001 | EP1127124A2 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/29/2001 | EP1127123A2 Cell surface glycoproteins |
| 08/29/2001 | EP1127120A1 Genomic and complete cdna sequences of human adipocyte-specific apm1 and biallelic markers thereof |
| 08/29/2001 | EP1127110A1 Modified exosomes and uses |
| 08/29/2001 | EP1127106A1 Glufosinate tolerant rice |
| 08/29/2001 | EP1127074A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 08/29/2001 | EP1127072A1 Method for detecting and purifying tcd8+ lymphocyte populations, specific of peptides present in the context of hla |
| 08/29/2001 | EP1127070A2 $i(IKAROS) ISOFORMS AND MUTANTS |
| 08/29/2001 | EP1127065A2 $i(chlamydia) antigens and corresponding dna fragments and uses thereof |
| 08/29/2001 | EP1127052A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 08/29/2001 | EP1126865A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 08/29/2001 | EP1126864A1 Binding moieties for human parvovirus b19 |
| 08/29/2001 | EP1126863A1 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
| 08/29/2001 | EP1126832A2 Conductance of improperly folded proteins through the secretory pathway |
| 08/29/2001 | EP1049807A4 Microparticles with multiple fluorescent signals |
| 08/29/2001 | EP0932700B1 Method of sequencing dna |
| 08/29/2001 | EP0866846A4 Determining antimicrobial agent sensitivity for paraffinophilic microorganisms |
| 08/29/2001 | EP0778899A4 Enrichment of fetal cells from maternal blood |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | EP0618925B1 Antisense oligonucleotides |
| 08/29/2001 | CN1310722A Method for marking a ribonucleic acid and resulting marked RNA fragments |
| 08/29/2001 | CN1310618A Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 08/29/2001 | CN1310236A Gene chip for the diagnosis of infectious disease hepatitis B virus, syphilis spirochete, AIDS virus and hepatitis C virus |
| 08/29/2001 | CN1310235A Method for detecting tubercle mycobacteria with polymerase chain reaction cloning REP13E12 repetitive sequence |
| 08/29/2001 | CN1070198C Isolated nucleic acid molecule of coded tumor rejection antigen precursor DAGE and its application |
| 08/29/2001 | CA2335436A1 Novel core 2 beta-1,6-n-acetylglycosaminyl transferase gene |
| 08/28/2001 | US6281352 Antiinflammatory agents |
| 08/28/2001 | US6281344 A dna covelently bound to protein through puromycin, that is added to the growing peptide chain by catalytic activity of a ribosomal peptidyl transferase; for isolating proteins with desired properties from pools of random amino acid sequences |
| 08/28/2001 | US6281330 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 08/28/2001 | US6281193 In autoimmune diseases in general, or graft-versus-host reactions in particular. |
| 08/28/2001 | US6281017 A nucleic acid molecule; involved in the producution of intermediates to isoprenoids |
| 08/28/2001 | US6281011 Random fragmentation of dna; transferring to expression vector; screening or selecting suppression |